Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aprea Therapeutics, Inc.

2.40
+0.02501.05%
Post-market: 2.400.00000.00%19:13 EDT
Volume:11.20K
Turnover:26.58K
Market Cap:13.04M
PE:-0.88
High:2.47
Open:2.30
Low:2.30
Close:2.38
Loading ...

BRIEF-Aprea Therapeutics Announces Agreement With MD Anderson Cancer Center To Explore Apr-1051 As A Potential Treatment For Head And Neck Squamous Cell Carcinoma (Hnscc)

Reuters
·
11 Mar

Aprea Therapeutics provides update on existing patent portfolio

TipRanks
·
06 Feb

Aprea Therapeutics Announces Strategic Ip Portfolio Evolution in DNA Damage Response (Ddr) Cancer Therapeutics

THOMSON REUTERS
·
05 Feb

BRIEF-Aprea Therapeutics Announces Twice Daily (Bid) Dosing Of Patients In ABOYA-119 Clinical Trial Of ATRN-119 To Potentially Optimize Clinical Outcomes

Reuters
·
11 Dec 2024

Aprea Therapeutics announces first patient dosed in ABOYA-119 Phase 1/2a trial

TIPRANKS
·
11 Dec 2024

Aprea Therapeutics- Dose Escalation in Aboya-119 Trial Expected to Continue With Both Once-Daily & Twice-Daily Dosing Schedules

THOMSON REUTERS
·
11 Dec 2024

Aprea Therapeutics Announces Twice Daily (Bid) Dosing of Patients in Aboya-119 Clinical Trial of Atrn-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward

THOMSON REUTERS
·
11 Dec 2024

Aprea Therapeutics Inc -Anticipates Phase 1 Readout in Second Half of 2025

THOMSON REUTERS
·
11 Dec 2024

Aprea Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Nov 2024

BRIEF-Aprea Therapeutics - Got Into At The Market Offering Agreement, May Offer & Sell Shares Of Common Stock Of Up To $3 Million From Time To Time - SEC Filing

Reuters
·
09 Nov 2024

Aprea Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Aprea Therapeutics Inc: Cash Runway for at Least Twelve Months

THOMSON REUTERS
·
07 Nov 2024

Aprea Therapeutics Q3 Net Income USD -3.8 Million

THOMSON REUTERS
·
07 Nov 2024

Pacira (PCRX) Q3 Earnings Beat Estimates

Zacks
·
07 Nov 2024

Insider Spends US$132k Buying More Shares In Aprea Therapeutics

Simply Wall St.
·
24 Oct 2024

Aprea Therapeutics presents preliminary results on APR-1051

TIPRANKS
·
23 Oct 2024